Skip to main content

WHITEBOX ADVISORS LLC

Position in SRPT — Sarepta Therapeutics, Inc.

CIK 1257391 MINNEAPOLIS, MN

Position in SRPT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2025
4 quarters on record

Derivatives in SRPT

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$4,669,696
PutShares
214,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

WHITEBOX ADVISORS LLC holds $52,720,052 across 1 Biotechnology name.

# Ticker Company Shares Value (USD) Open

All Filings in SRPT

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,669,696 214,600
2025-12-31 $17,448,416 810,800
2025-09-30 $15,624,116 810,800
2025-06-30 $12,219,660 714,600